Olympian Clinical Research

AUGUST 19, 2022

Biologic drugs that are created from living cells and target a specific part of the immune system. About 30% of children with eczema have a food allergy, and many children may develop asthma or hay fever. Insomnia, allergies, and asthma may also be more common in children with eczema. Symptoms of Pediatric Eczema.

Clinical Research 52

Clinical Research Allergies Doctors Doctor 52

The Pharma Data

JANUARY 12, 2021

Virology, Respiratory, Dermatology, Allergy, & Rheumatology) in early & late stage Clinical Development and in Medical Affairs, with a strong track record for Developing and Accelerating Phase I–IV programs. He has in depth Global Development Expertise (e.g. We are delighted to have Dr. Graham join the Tiziana team.

Life Science 52

Life Science Antibody In-Vivo In-Vitro 52

Trialfacts

DECEMBER 18, 2024

Researchers are exploring a new investigational study drug called Eltrekibart to see if it can help. They will be randomly assigned to take the study investigational study drug or a placebo. The goal of this study is to understand how safe Eltrekibart is and whether it works better than a placebo for people living with HS.

Research 52

Research Allergies Hormones Drugs 52

Scienmag

MARCH 3, 2021

Results could lead to better drugs used to fight inflammation At the beginning of an immune response, a molecule known to mobilize immune cells into the bloodstream, where they home in on infection sites, rapidly shifts position, a new study shows.

Immune Response 57

Immune Response Drugs Research Dermatology 57

Scienmag

APRIL 8, 2021

Early results show that a new combination drug therapy is safe and effective against advanced skin cancer in patients who were not able to have their tumors surgically removed.

Drugs 45

Drugs Research Clinical Trials Clinical Trials 45

The Pharma Data

MAY 18, 2021

In the United States, the division benefited particularly from the launch of the cancer drug Nubeqa™. in sales of the ophthalmology drug Eylea™ was driven by positive development in Japan and markedly higher volumes in Europe, China and Canada. percent) and the cancer drug Nexavar™ (Fx & portfolio adj. percent and 4.7

Sales 40

Sales Production Marketing Containment 40

pharmaphorum

SEPTEMBER 29, 2022

Sanofi and Regeneron have claimed the first approval in the US for a drug for prurigo nodularis, after the FDA gave a green light to Dupixent as a treatment for adults with the rare skin disease following a priority review. Development in peanut allergy has also been discontinued, said Sanofi in its second-quarter update.

Drugs 69

Drugs Immune Response Allergies Sales 69

The Pharma Data

OCTOBER 27, 2020

Moderate-to-severe cases of psoriasis are treated with drugs that suppress the immune system. John’s Institute of Dermatology in London, who co-leads the registry. The findings were recently published online in the Journal of Allergy and Clinical Immunology. TUESDAY, Oct. ’s National Institute for Health Research.

Dermatology 52

Dermatology Allergies Research Drugs 52

The Pharma Data

DECEMBER 30, 2020

Food and Drug Administration in 2018 and is currently the only approved Factor Xa inhibitor reversal agent. Nestlé and Peanut Allergies – In August, Nestlé Health Science acquired the outstanding stakes of Aimmune for $2.6 That company’s breast cancer treatment Trodelvy, which was granted accelerated approval from the U.S.

Antibody 52

Antibody Allergies Branding Dermatology 52

The Pharma Data

JULY 8, 2021

AstraZeneca’s Biologics License Application (BLA) for tezepelumab has been accepted and granted Priority Review for the treatment of asthma from the US Food and Drug Administration (FDA). 1 The Prescription Drug User Fee Act date, the FDA action date for their regulatory decision, is during the first quarter of 2022.

Trials 52

Trials Medicine Sales Clinical Trials 52

The Pharma Data

APRIL 28, 2021

These and other data from real-world settings and clinical trials, including the Dupixent open-label extension (OLE) trials, will be presented at the American Academy of Dermatology (AAD VMX 2021), April 23-25, and at the 20 th European Society for Pediatric Dermatology Annual Meeting (ESPD 2021), May 12-14.

Dermatology 40

Dermatology Trials Clinical Trials Clinical Trials 40

The Pharma Data

APRIL 13, 2022

“I’m pleased that TAKHZYRO has met these key objectives and I look forward to Takeda sharing further insights with the HAE community in the near future,” said Dr. Marcus Maurer, Professor of Dermatology and Allergy Charité – Universitätsmedizin Berlin, Germany and principal investigator of SHP643-301.

Dermatology 52

Dermatology Allergies Genetics Antibody 52

Bioengineer

JULY 20, 2021

Food and Drug Administration (FDA) has granted approval to Octapharma USA for Octagam® 10% [Immune Globulin Intravenous (Human)], the first and only intravenous immunoglobulin (IVIg) to be indicated for the treatment of adult dermatomyositis, a rare immune-mediated inflammatory disease. Credit: Octapharma. PARAMUS, N.J. – The U.S.

FDA Approval 40

FDA Approval Clinical Trials Clinical Trials Trials 40

XTalks

AUGUST 2, 2023

Pfizer’s Top 5 Best-Selling Drugs of 2022: 1) Comirnaty Comirnaty is an mRNA-based vaccine indicated for the prevention of COVID-19. Comirnaty was first approved by the US Food and Drug Administration (FDA) in August 2021 for individuals over the age of 16. billion the drug generated in 2021. billion in 2022. billion, a 26.55

Sales 98

Sales Manufacturing FDA Approval Life Science 98

XTalks

DECEMBER 20, 2023

These advancements and trends addressed important industry challenges and offered opportunities to foster innovations and solutions in areas including drug development, healthcare and medical devices. The shortages have been partly blamed on the off-label prescribing of the drugs for weight loss.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

The Pharma Data

JANUARY 24, 2021

It inked a deal with the National Institute of Allergy and Infectious Diseases (NIAID) to launch a Phase I trial. The drug appears to inhibit IL-6, IL-1beta, TNF-alpha and other pro-inflammatory cytokines and chemokines. The trial will investigate 105 patients for the drug, which is made up of autologous CD34+ cells.

Trials 52

Trials Allergies In-Vitro Antibody 52

XTalks

JANUARY 2, 2025

The immunology drug market is a dynamic landscape driven by innovation, expanded indications and competitive strategies. From biologics to biosimilars, the top-performing drugs in this sector not only offer life-changing therapies for patients but also generate billions in revenue for pharmaceutical companies.

Sales 85

Sales FDA Approval Drugs Marketing 85

XTalks

DECEMBER 24, 2024

As of December 4, 2024, here are the top ten new prescription drug commercials by TV impressions (data from ispot.tv) that dominated television screens in 2024. million, AbbVies TV ad Stuck: Needed More for its antipsychotic drug Vraylar (cariprazine) took the top spot for new prescription drug ads.

Drugs 105

Drugs Allergies Vaccine Vaccination 105